J&J Rises on EU Nod To Resume Vaccine Rollout

J&J Rises on EU Nod To Resume Vaccine Rollout By Investing.com

J&J Rises on EU Nod To Resume Vaccine Rollout

By Dhirendra Tripathi Investing.com – Shares of Johnson & Johnson (NYSE:JNJ) erased their early losses and were up just short of 3% on securing the European regulator’s nod to resume supplies of its Covid-19 shots. The company was able to convince the European Medicines Agency that the risk-reward ratio favored the application of the jabs.

Live News Feed

News Feed featuring the top articles in the finance world from global publications such as Financial Times and the Economist.

Click here to view

Powered by © Neon Accelerator

From the Web

Shell Norco. Louisiana. hydrocracker partially shut to repair leak -sources

April 26, 2021 | From the web

Shell Norco. Louisiana. hydrocracker partially shut to repair leak -sources | Financial News

Read More >

LIVE MARKETS-Inflation chatter on front burner this earnings season

April 26, 2021 | From the web

LIVE MARKETS-Inflation chatter on front burner this earnings season | Financial News

Read More >

UK earnings. trading statements calendar – next 7 days

April 26, 2021 | From the web

UK earnings. trading statements calendar – next 7 days | Financial News

Read More >

UK records 2.064 new COVID cases. 6 deaths on Monday

April 26, 2021 | From the web

UK records 2.064 new COVID cases. 6 deaths on Monday | Financial News

Read More >
Go to Top